insights_auto
Why is AVE down 9,09%?
Dive Deeperchevron_right
AVE:ASX
Avecho Biotechnology Ltd
A$0,010
arrow_downward
-9,09%(-0,0010) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVE...
Open
A$0,01
High
A$0,01
Low
A$0,01
Mkt. cap
42,50 ລ້ານ
Avg. vol.
4,18 ລ້ານ
Volume
1,01 ລ້ານ
52-wk high
A$0,03
52-wk low
A$0,01
EPS
A$-0,00
Shares outstanding
3,86 ຕື້
No. of employees
15
Open
A$0,01
High
A$0,01
Low
A$0,01
Mkt. cap
42,50 ລ້ານ
Avg. vol.
4,18 ລ້ານ
Volume
1,01 ລ້ານ
52-wk high
A$0,03
52-wk low
A$0,01
EPS
A$-0,00
Shares outstanding
3,86 ຕື້
No. of employees
15
News stories
From web sources and news partners
TradingKey
·
6 ຊົ່ວໂມງກ່ອນ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
6 ຊົ່ວໂມງກ່ອນ
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
24/7 Wall St.
·
9 ຊົ່ວໂມງກ່ອນ
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
13 ຊົ່ວໂມງກ່ອນ
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
About Avecho Biotechnology Ltd
CEOPaul Gavin Ph.D.
Employees15
Founded1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteavecho.com.au